Publications by authors named "Maarten Limper"

Claim this Profile
P
Problem Solved? An Individual Ratio between Point-of-Care and Venous International Normalized Ratio Values in Two Patients with Antiphospholipid Syndrome: Two Case Reports.
Bettina C Geertsema-Hoeve, Massimo Radin, Savino Sciascia, Rolf T Urbanus, Albert Huisman, Maarten Limper

TH Open· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of pregnancy outcomes in SLE - Authors' reply.
Merlijn Wind, Juan J Fierro, Kitty W M Bloemenkamp, Karina de Leeuw, A Titia Lely, Maarten Limper

Lancet Rheumatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of autoantibodies with the IFN signature and NETosis in patients with systemic lupus erythematosus.
Ellen D Kaan, Tammo E Brunekreef, Julia Drylewicz, Lucas L van den Hoogen, Maarten van der Linden, Maarten Limper

J Transl Autoimmun· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostics for antiphospholipid syndrome following early-onset fetal growth restriction: A retrospective cohort study.
Daphne N Philippi, Mette Van de Meent, Saskia Haitjema, Maarten Limper, Titia Lely

Lupus· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy outcome predictors in systemic lupus erythematosus: a systematic review and meta-analysis.
Merlijn Wind, Juan J Fierro, Kitty W M Bloemenkamp, Karina de Leeuw, A Titia Lely, Maarten Limper

Lancet Rheumatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving organisation to improve care: ERN ReCONNET organisational reference model for systemic sclerosis patients' care pathway.
Rosaria Talarico, Diana Marinello, Ilaria Palla, Sara Cannizzo, Ilaria Galetti, Maarten Limper

J Scleroderma Relat Disord· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in Belgium.
Paul G Kemps, F J Sherida H Woei-A-Jin, Patrick Schöffski, Thomas Tousseyn, Isabelle Vanden Bempt, Maarten Limper

Blood Neoplasia· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Intestinal Microbiome Intervention Affects Biochemical Disease Activity in Patients with Antiphospholipid Syndrome.
Valérie L B I Jansen, Dagmar J M van Mourik, Mark Davids, Kika van Bergen En Henegouwen, Tessa Noordermeer, Maarten Limper

TH Open· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The predictive value of antinuclear antibodies in patients with suspected connective tissue disease for the development of connective tissue diseases.
Tammo E Brunekreef, Hélène B van den Heuvel, Maarten Limper, Helen Leavis, Jaap M van Laar

Clin Exp Rheumatol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult patient diagnosed with Muckle-Wells syndrome, antiphospholipid syndrome and glomerular haematuria.
Sofie Lm Blokland, Maarten Limper, Albertien M van Eerde, Hilde Hf Remmelts

BMJ Case Rep· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria.
Medha Barbhaiya, Stephane Zuily, Ray Naden, Alison Hendry, Florian Manneville, Maarten Limper

Arthritis Rheumatol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2023 ACR/EULAR antiphospholipid syndrome classification criteria.
Medha Barbhaiya, Stephane Zuily, Ray Naden, Alison Hendry, Florian Manneville, Maarten Limper

Ann Rheum Dis· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies interfere with cleavage of factor V(a) by activated protein C.
Tessa Noordermeer, Soumaya Chemlal, Janna J Jansma, Vossa van der Vegte, Roger E G Schutgens, Maarten Limper

J Thromb Haemost· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Routine Lupus Anticoagulant Sensitive aPTT Testing Can Prevent Unnecessary LA Testing.
Bob Smit, Francisca Hudig, Jan-Hendrik Venhuizen, Saskia Haitjema, Maarten Limper

Clin Appl Thromb Hemost· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products.
Rosaria Talarico, Giuseppe Alvise Ramirez, Sofia C Barreira, Chiara Cardamone, Paola Triggianese, Maarten Limper

Clin Exp Rheumatol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interference in point-of-care international normalized ratio monitoring in patients with lupus anticoagulant is correlated with anti-β2-glycoprotein I antibody titers.
Tessa Noordermeer, Rolf T Urbanus, Chong Y Wong, Janna J Jansma, Nynke M Wiersma, Maarten Limper

Res Pract Thromb Haemost· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial.
Mieke van Schaik, Eline J Arends, Darius Soonawala, Ellen van Ommen, Karina de Leeuw, Maarten Limper

Trials· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrence risk of venous thromboembolism associated with systemic lupus erythematosus: A retrospective cohort study.
Soerajja Bhoelan, Jaime Borjas Howard, Vladimir Tichelaar, Paul van Daele, Liesbeth Hak, Maarten Limper

Res Pract Thromb Haemost· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features and immune-related protein patterns of anti-MDA5 positive clinically amyopathic dermatomyositis Dutch patients.
Marjolein P M Hensgens, Eveline M Delemarre, Julia Drylewicz, Mareye Voortman, Roline M Krol, Maarten Limper

Rheumatology (Oxford)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lupus anticoagulant associates with thrombosis in patients with COVID-19 admitted to intensive care units: A retrospective cohort study.
Tessa Noordermeer, Roger E G Schutgens, Chantal Visser, Emma Rademaker, Moniek P M de Maat, Maarten Limper

Res Pract Thromb Haemost· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microarray analysis of autoantibodies can identify future Systemic Lupus Erythematosus patients.
Tammo E Brunekreef, Leon C Reteig, Maarten Limper, Saskia Haitjema, Jorge Dias

Hum Immunol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET.
Rosaria Talarico, Silvia Aguilera, Tobias Alexander, Zahir Amoura, Janette Andersen, Maarten Limper

Clin Exp Rheumatol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare clinical manifestations in systemic lupus erythematosus: a review on frequency and clinical presentation.
Chiara Tani, Elena Elefante, Laurent Arnaud, Sofia C Barreira, Inita Bulina, Maarten Limper

Clin Exp Rheumatol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2021 DORIS definition of remission in SLE: final recommendations from an international task force.
Ronald F van Vollenhoven, George Bertsias, Andrea Doria, David Isenberg, Eric Morand, Maarten Limper

Lupus Sci Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Diagnosis and treatment of patients with antiphospholipid syndrome: a mixed-method evaluation of care in The Netherlands.
Mirthe J Klein Haneveld, Caro H C Lemmen, Tammo E Brunekreef, Marc Bijl, A J Gerard Jansen, Maarten Limper

Rheumatol Adv Pract· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis